Suramin, hydrocortisone, and retinoic acid modify inhibitory effects of 1,25-dihydroxyvitamin D3 on prostatic epithelial cells

This publication has 17 references indexed in Scilit:

• Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer
  Urologic Oncology: Seminars and Original Investigations, 1995
• Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
  Endocrinology, 1995
• Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.
  Endocrinology, 1993
• Vitamin A regulates proliferation and differentiation of human prostatic epithelial cells
  The Prostate, 1993
• Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation
  The Journal of Steroid Biochemistry and Molecular Biology, 1991
• Culture of prostatic epithelial cells from ultrasound-guided needle biopsies
  The Prostate, 1991
• The effects of short-term, high-dose treatment with prednisone on the nuclear uptake of 1,25-dihydroxyvitamin D3 in monocytes from normal human subjects
  Metabolism, 1988
• Retinoic acid modulation of 1,25(OH)2 vitamin D3 receptors and bioresponse in bone cells: Species differences between rat and mouse
  Biochemical and Biophysical Research Communications, 1985
• Clonal growth of normal human epidermal keratinocytes in a defined medium
  Journal of Cellular Physiology, 1982
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976